Format

Send to

Choose Destination
Oncotarget. 2018 Feb 23;9(15):12534. doi: 10.18632/oncotarget.24557. eCollection 2018 Feb 23.

Correction: miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.

Author information

1
Department of Experimental Oncology and Molecular Medicine, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
2
Department of Experimental Oncology and Molecular Medicine, Functional Genomics Core Facility, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
3
Laboratory of Pre-Clinical and Translational Research, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture (PZ), Italy.
4
Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
5
Department of Diagnostic Imaging and Radiotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
6
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
7
Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.7262.].

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center